Glutathione S-transferase: differential expression of α, μ, and π isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma

Human Pathology

Volumn 38, Issue 9, 2007, Pages 1394-1401

  Bostwick, David G ^a   Meiers, Isabelle ^a   Shanks, Jonathan H ^b  

^a BOSTWICK LABORATORIES   (United States)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Antioxidant enzymes; Carcinogenesis; Glutathione S transferase; Oxygen free radicals; Prostate; Prostatic neoplasms

Indexed keywords

ANTIBODY; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1;

ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; SECRETORY CELL;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 34547850207     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.02.008     Document Type: Article

References (87)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Mimeault M., and Batra S.K. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 27 (2006) 1-22
3. Hughes C., Murphy A., Martin C., et al. Molecular pathology of prostate cancer. J Clin Pathol 58 (2005) 673-684
4. Bostwick D.G., Pacelli A., and Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 29 (1996) 117-134
5. Scandalios J.G. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 38 (2005) 995-1014
6. Nelson W.G., DeWeese T.L., and DeMarzo A.M. The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev 21 (2002) 3-16
7. Nebert D.W., and Vasiliou V. Analysis of the glutathione S-transferase (GST) gene family. Hum Genomics 1 (2004) 460-464
8. Kantor R.R., Giardina S.L., Bartolazzi A., et al. Monoclonal antibodies to glutathione S-transferase pi-immunohistochemical analysis of human tissues and cancers. Int J Cancer 47 (1991) 193-201
9. Toffoli G., Viel A., Tumiotto L., et al. Expression of glutathione-S-transferase-pi in human tumours. Eur J Cancer 28A (1992) 1441-1446
10. Inoue T., Ishida T., Sugio K., et al. Glutathione S-transferase pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma. Respiration 62 (1995) 223-227
11. Green J.A., Robertson L.J., and Clark A.H. Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 68 (1993) 235-239
12. Satta T., Isobe K., Yamauchi M., et al. Expression of MDR1 and glutathione S-transferase-pi genes and chemosensitivities in human gastrointestinal cancer. Cancer 69 (1992) 941-946
13. Bentz B.G., Haines III G.K., and Radosevich J.A. Glutathione S-transferase pi in squamous cell carcinoma of the head and neck. Laryngoscope 110 (2000) 1642-1647
14. Trachte A.L., Suthers S.E., Lerner M.R., et al. Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma. Am J Surg 184 (2002) 642-648
15. Simic T., Mimic-Oka J., Savic-Radojevic A., et al. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder. Urology 65 (2005) 1035-1040
16. Niitsu Y., Takahashi Y., Saito T., et al. Serum glutathione-S-transferase-pi as a tumor marker for gastrointestinal malignancies. Cancer 63 (1989) 317-323
17. Toffoli G., Frustaci S., Tumiotto L., et al. Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness. Ann Oncol 3 (1992) 63-69
18. Randall B.J., Angus B., Akiba R., et al. Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study. Br J Cancer 62 (1990) 614-618
19. Di Ilio C., Aceto A., Bucciarelli T., et al. Glutathione transferase isoenzymes in normal and neoplastic human kidney tissue. Carcinogenesis 12 (1991) 1471-1475
20. Ranganathan S., and Tew K.D. Immunohistochemical localization of glutathione S-transferases alpha, mu, and pi in normal tissue and carcinomas from human colon. Carcinogenesis 12 (1991) 2383-2387
21. Strange R.C., Spiteri M.A., Ramachandran S., et al. Glutathione-S-transferase family of enzymes. Mutat Res 482 (2001) 21-26
22. Coles B., and Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25 (1990) 47-70
23. Di Ilio C., Aceto A., Bucciarelli T., et al. Glutathione transferase isoenzymes from human prostate. Biochem J 271 (1990) 481-485
24. Di Paolo O.A., Teitel C.H., Nowell S., et al. Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways. Int J Cancer 117 (2005) 8-13
25. Board P.G., and Webb G.C. Isolation of a cDNA clone and localization of human glutathione S-transferase 2 genes to chromosome band 6p12. Proc Natl Acad Sci U S A 84 (1987) 2377-2381
26. Ross V.L., Board P.G., and Webb G.C. Chromosomal mapping of the human mu class glutathione S-transferases to 1p13. Genomics 18 (1993) 87-91
27. Board P.G., Webb G.C., and Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53 (1989) 205-213
28. Awasthi S., Bajpai K.K., Piper J.T., et al. Interactions of melphalan with glutathione and the role of glutathione S-transferase. Drug Metab Dispos 24 (1996) 371-374
29. Ciaccio P.J., Tew K.D., and LaCreta F.P. The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione. Cancer Commun 2 (1990) 279-285
30. Morrow C.S., and Cowan K.H. Glutathione S-transferases and drug resistance. Cancer Cells 2 (1990) 15-22
31. Morrow C.S., Smitherman P.K., Diah S.K., et al. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells. J Biol Chem 273 (1998) 20114-20120
32. Pickett C.B., Telakowski-Hopkins C.A., Argenbright L., et al. Regulation of glutathione S-transferase mRNAs by phenobarbital and 3-methylcholanthrene: analysis using cDNA probes. Biochem Soc Trans 12 (1984) 71-74
33. Hayes J.D., and Strange R.C. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 22 (1995) 193-207
34. Mannervik B., and Danielson U.H. Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem 23 (1988) 283-337
35. Katahira T., Takayama T., Miyanishi K., et al. Plasma glutathione S-transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV). Clin Cancer Res 10 (2004) 7934-7940
36. Sundberg A.G., Nilsson R., Appelkvist E.L., et al. Immunohistochemical localization of alpha and pi class glutathione transferases in normal human tissues. Pharmacol Toxicol 72 (1993) 321-331
37. Millar D.S., Ow K.K., Paul C.L., et al. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 18 (1999) 1313-1324
38. Arriazu R., Pozuelo J.M., Martin R., et al. Quantitative and immunohistochemical evaluation of PCNA, androgen receptors, apoptosis, and glutathione-S-transferase P1 on preneoplastic changes induced by cadmium and zinc chloride in the rat ventral prostate. Prostate 63 (2005) 347-357
39. De Marzo A.M., Marchi V.L., Epstein J.I., et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155 (1999) 1985-1992
40. Montironi R., Mazzucchelli R., Pomante R., et al. Immunohistochemical expression of pi class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride. J Clin Pathol 52 (1999) 350-354
41. Cookson M.S., Reuter V.E., Linkov I., et al. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol 157 (1997) 673-676
42. Murray G.I., Taylor V.E., McKay J.A., et al. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. J Pathol 177 (1995) 147-152
43. Moskaluk C.A., Duray P.H., Cowan K.H., et al. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 79 (1997) 1595-1599
44. Oberley T.D., Zhong W., Szweda L.I., et al. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44 (2000) 144-155
45. Nonogaki T., Noda Y., Narimoto K., et al. Localization of CuZn-superoxide dismutase in the human male genital organs. Hum Reprod 7 (1992) 81-85
46. Bostwick D.G., Dousa M.K., Crawford B.G., et al. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Surg Pathol 18 (1994) 1240-1246
47. Grignon D.J., Abdel-Malak M., Mertens W.C., et al. Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation. Mod Pathol 7 (1994) 186-189
48. Cairns J., Wright C., Cattan A.R., et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 166 (1992) 19-25
49. Gilbert L., Elwood L.J., Merino M., et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11 (1993) 49-58
50. Yamanaka M., Watanabe M., Yamada Y., et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 106 (2003) 382-387
51. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2 (2002) 210-219
52. Jeronimo C., Usadel H., Henrique R., et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93 (2001) 1747-1752
53. Harden S.V., Sanderson H., Goodman S.N., et al. Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 95 (2003) 1634-1637
54. Harden S.V., Guo Z., Epstein J.I., et al. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 169 (2003) 1138-1142
55. Brooks J.D., Weinstein M., Lin X., et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 7 (1998) 531-536
56. Lee W.H., Morton R.A., Epstein J.I., et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A 91 (1994) 11733-11737
57. Lin X., Tascilar M., Lee W.H., et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 159 (2001) 1815-1826
58. Jeronimo C., Varzim G., Henrique R., et al. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 11 (2002) 445-450
59. Jeronimo C., Henrique R., Hoque M.O., et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 10 (2004) 8472-8478
60. Harden S.V., Tokumaru Y., Westra W.H., et al. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 9 (2003) 1370-1375
61. Esteller M., Corn P.G., Baylin S.B., et al. A gene hypermethylation profile of human cancer. Cancer Res 61 (2001) 3225-3229
62. Tchou J.C., Lin X., Freije D., et al. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 16 (2000) 663-676
63. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30 (1995) 445-600
64. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6 (1997) 733-743
65. Rebbeck T.R., Walker A.H., Jaffe J.M., et al. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 283-287
66. Zimniak P., Nanduri B., Pikula S., et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 224 (1994) 893-899
67. Kelada S.N., Kardia S.L., Walker A.H., et al. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 9 (2000) 1329-1334
68. Autrup J.L., Thomassen L.H., Olsen J.H., et al. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 8 (1999) 525-532
69. Nam R.K., Zhang W.W., Trachtenberg J., et al. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 1429-1437
70. Beer T.M., Evans A.J., Hough K.M., et al. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer Prostatic Dis 5 (2002) 22-27
71. Medeiros R., Vasconcelos A., Costa S., et al. Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 58 (2004) 414-420
72. Gsur A., Haidinger G., Hinteregger S., et al. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 95 (2001) 152-155
73. Kote-Jarai Z.E.D., Edwards S.M., Jefferies S., et al., CRC/BPG UK Familial Prostate Cancer Study Collaborators. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 11 (2001) 325-330
74. Acevedo C., Opazo J.L., Huidobro C., et al. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 57 (2003) 111-117
75. Agalliu I., Langeberg W.J., Lampe J.W., et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. Prostate 66 (2006) 146-156
76. Kidd L.C., Woodson K., Taylor P.R., et al. Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 12 (2003) 317-320
77. Ntais C., Polycarpou A., and Ioannidis J.P. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14 (2005) 176-181
78. Wadelius M., Autrup J.L., Stubbins M.J., et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9 (1999) 333-340
79. Shepard T.F., Platz E.A., Kantoff P.W., et al. No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 9 (2000) 1267-1268
80. Debes J.D., Yokomizo A., McDonnell S.K., et al. Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet 155 (2004) 82-86
81. Luscombe C.J., French M.E., Liu S., et al. Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer. Cancer Detect Prev 26 (2002) 376-380
82. Mao G.E., Morris G., Lu Q.Y., et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 28 (2004) 368-374
83. Egan K.M., Cai Q., Shu X.O., et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 13 (2004) 197-204
84. Ye Z., and Parry J.M. A meta-analysis of 20 case-control studies of the glutathione S-transferase M1 (GSTM1) status and colorectal cancer risk. Med Sci Monit 9 (2003) SR83-SR91
85. Hashibe M., Brennan P., Strange R.C., et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 1509-1517
86. Benhamou S., Lee W.J., Alexandrie A.K., et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23 (2002) 1343-1350
87. Engel L.S., Taioli E., Pfeiffer R., et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 156 (2002) 95-109